How to Get Sildenafil (Generic) in Michigan

At a glance
- Prescription required / Yes, Schedule IV equivalent; no OTC path in MI
- Telehealth prescribing legal / Yes, Michigan permits telehealth Rx for sildenafil
- 503A compounding available / Yes, licensed Michigan 503A pharmacies can compound sildenafil 20 to 100 mg
- Michigan Medicaid / Covered with prior authorization for erectile dysfunction
- Standard dosing / 25 to 100 mg on demand, 30 to 60 minutes before sexual activity
- Prescribing clinicians / MDs, DOs, NPs (with prescriptive authority), and PAs
- Typical generic cost / $0.30, $2.00 per tablet at Michigan retail pharmacies
- Common lab prerequisite / Cardiovascular risk screening, lipid panel, fasting glucose
- Time to receive / Same-day pickup or 2 to 5 business days via mail-order pharmacy
- FDA-approved indications / Erectile dysfunction (Viagra, 25 to 100 mg) and pulmonary arterial hypertension (Revatio, 20 mg)
Michigan Prescribing Law and Telehealth Rules for Sildenafil
Generic sildenafil is classified as a prescription-only medication in Michigan under both state pharmacy law and federal FDA regulations. Any Michigan-licensed physician (MD or DO), nurse practitioner with prescriptive authority, or physician assistant operating under a practice agreement can write the prescription. Michigan Public Health Code Section 333.17211 does not impose additional state-level scheduling on PDE5 inhibitors beyond the federal prescription requirement.
Michigan's telehealth statute (Public Act 3 of 2021) permits synchronous audio-video visits as the basis for prescribing, which means a patient does not need an in-person office visit to receive a sildenafil prescription. The Michigan Department of Licensing and Regulatory Affairs (LARA) requires the telehealth provider to hold an active Michigan medical license or to practice under an interstate compact that covers MI. The prescriber must document a clinical evaluation, confirm the absence of contraindications (especially nitrate use), and enter the prescription into Michigan's MAPS (Michigan Automated Prescription System) database if the drug is a controlled substance. Sildenafil itself is not a Michigan-scheduled controlled substance, so MAPS reporting is not mandatory, though many pharmacies still verify the patient's history through the system as part of standard dispensing protocols.
Telehealth visits for erectile dysfunction typically last 10 to 20 minutes. The clinician will ask about symptom duration, cardiovascular history, current medications, and sexual health goals. No physical exam is technically required under Michigan telehealth law for this drug class, though clinicians may request recent lab work if the patient has not seen a primary care provider within the past 12 months.
What Labs Are Needed Before a Sildenafil Prescription
Most prescribers will order or review baseline cardiovascular labs before writing a sildenafil prescription, because PDE5 inhibitors produce systemic vasodilation and carry a mean blood pressure reduction of 8.4/5.5 mmHg according to pooled data from the original Goldstein et al. (1998) trial in the New England Journal of Medicine. That trial (N=532) established sildenafil's efficacy for erectile dysfunction and documented the hemodynamic profile that now shapes pre-prescribing lab requirements.
A standard pre-prescribing workup includes a lipid panel (total cholesterol, LDL, HDL, triglycerides), fasting glucose or HbA1c, a basic metabolic panel (to check renal function via eGFR and serum creatinine), and a resting blood pressure reading. Patients with diabetes have a 52% prevalence of erectile dysfunction according to a meta-analysis published in Diabetic Medicine, so HbA1c screening is especially relevant for this population. The prescriber may also check testosterone levels if hypogonadism is suspected.
Michigan does not mandate specific labs by statute, but the standard of care in the state follows the American Urological Association (AUA) guidelines, which recommend cardiovascular risk stratification before initiating PDE5 inhibitor therapy. Patients in the "intermediate cardiovascular risk" category per the Princeton III Consensus may need a stress test or cardiology clearance before starting sildenafil.
Many telehealth platforms operating in Michigan will accept lab results from the past 6 to 12 months. If a patient has no recent labs, most services can order them through Quest Diagnostics or Labcorp locations across Michigan (there are over 400 combined draw sites in the state).
Sildenafil Dosing: What Michigan Prescribers Typically Start With
The FDA-approved labeling for sildenafil recommends a starting dose of 50 mg taken approximately one hour before sexual activity. The dose can be adjusted to 25 mg or increased to 100 mg based on efficacy and tolerability. The maximum recommended frequency is once per 24-hour period.
In the landmark Goldstein et al. trial, 69% of all attempts at intercourse were successful at the 50 mg dose, compared with 22% on placebo (P<0.001) [1]. At 100 mg, the success rate reached 78%. These figures have been reproduced across multiple post-marketing studies and remain the standard benchmark for PDE5 inhibitor efficacy.
Michigan prescribers commonly start patients at 50 mg for the first four attempts and then titrate. Patients over 65, those taking CYP3A4 inhibitors (such as erythromycin or ketoconazole), or patients with hepatic impairment typically start at 25 mg per the FDA label. The 20 mg tablet (originally branded as Revatio for pulmonary arterial hypertension) is sometimes prescribed off-label for erectile dysfunction at doses of 40 to 60 mg, because the 20 mg tablet can be significantly cheaper on a per-milligram basis, especially at Michigan pharmacies that do not accept insurance for ED medications.
Sildenafil reaches peak plasma concentration in approximately 60 minutes when taken on an empty stomach. A high-fat meal can delay absorption by roughly 60 minutes and reduce peak concentration (Cmax) by 29%, based on pharmacokinetic data in the FDA label. Michigan clinicians generally advise patients to take the medication on an empty stomach or after a light meal for the most predictable response.
Michigan Telehealth Providers That Prescribe Sildenafil
Several national telehealth platforms hold active Michigan medical licenses and prescribe generic sildenafil to MI residents. HealthRX operates in Michigan and offers asynchronous or synchronous consultations with licensed providers who can prescribe sildenafil 25 to 100 mg and send the prescription electronically to a Michigan pharmacy of the patient's choice.
Other platforms active in Michigan include Hims, Ro, and Lemonaid Health. Pricing structures differ: some charge a flat consultation fee ($15, $75) and allow the patient to fill the prescription independently, while others bundle the medication and consultation into a single monthly subscription ($20, $90/month depending on dose and quantity).
When evaluating telehealth options, Michigan residents should verify three things. First, the prescriber must have an active Michigan license, which can be checked at Michigan LARA's license verification portal. Second, the platform should use a DEA-registered prescriber, even though sildenafil is not a controlled substance in Michigan, because registration indicates regulatory compliance. Third, the pharmacy fulfilling the prescription must hold a valid Michigan Board of Pharmacy license if it ships medications into the state.
Turnaround times for Michigan telehealth sildenafil prescriptions vary. Asynchronous platforms (where the patient fills out a questionnaire reviewed by a clinician) can generate a prescription within 2 to 24 hours. Synchronous video visits produce a prescription immediately at the end of the consultation. Mail-order delivery within Michigan typically takes 2 to 5 business days from shipment.
503A Compounding Pharmacies in Michigan
Michigan licenses 503A compounding pharmacies under the authority of the Michigan Board of Pharmacy, consistent with Section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies can compound sildenafil in custom strengths (for example, 30 mg, 35 mg, or 75 mg tablets or troches) when a prescriber determines that a commercially available dosage form does not meet the patient's clinical needs.
A 503A pharmacy must compound sildenafil in response to a valid, patient-specific prescription. It cannot manufacture bulk quantities for general dispensing (that would require 503B outsourcing facility registration). Michigan has approximately 200 pharmacies with active compounding licenses, concentrated in the Detroit metro area, Grand Rapids, Ann Arbor, and Lansing.
Compounded sildenafil may be useful for patients who need a non-standard dose, who have difficulty swallowing tablets (sublingual troches or oral suspensions are common alternatives), or who have allergies to inactive ingredients in commercially manufactured tablets. Typical costs for compounded sildenafil at Michigan 503A pharmacies range from $1.50 to $4.00 per dose, depending on the formulation. Because compounded medications are not FDA-approved finished products, most insurance plans, including Michigan Medicaid, will not cover them.
Michigan Decision Framework: Retail Generic vs. 503A Compounded vs. Telehealth-Bundled Sildenafil
Choosing the right access pathway depends on insurance status, dose flexibility needs, and time sensitivity. This framework helps Michigan patients select the optimal route.
Retail generic (best for insured patients or high-volume users): The patient gets a prescription from any licensed clinician, fills it at CVS, Walgreens, Meijer, or any Michigan retail pharmacy. Generic sildenafil 20 mg tablets cost as low as $0.30 per tablet with a GoodRx-type coupon; 50 mg and 100 mg tablets run $0.50 to $2.00 each. Meijer pharmacies in Michigan often have the lowest cash prices for generic sildenafil among brick-and-mortar chains. This route is fastest for patients who already have a prescription and want same-day pickup.
503A compounded (best for non-standard doses or formulations): A prescriber writes for a specific compounded formulation (e.g., sildenafil 35 mg sublingual troche). The patient fills the prescription at a licensed Michigan 503A pharmacy. Costs are higher ($1.50, $4.00/dose), turnaround is 1 to 3 business days for compounding, and insurance coverage is unlikely. Choose this route when commercial tablets don't meet clinical needs.
Telehealth-bundled (best for new patients without an existing prescriber): The patient completes an online consultation, receives a prescription, and gets medication shipped to their Michigan address. Total cost ranges from $20 to $90/month. This route is the most convenient for patients who have not seen a doctor recently, do not have a primary care provider in Michigan, or prefer the privacy of home delivery.
For Michigan Medicaid recipients, the retail generic route with prior authorization is the most cost-effective option. The PA process typically takes 3 to 7 business days and requires documentation of the erectile dysfunction diagnosis plus evidence that the medication is not being prescribed for cosmetic or recreational purposes.
Michigan Medicaid and Insurance Coverage for Sildenafil
Michigan Medicaid covers generic sildenafil for erectile dysfunction, but it requires prior authorization (PA). The PA process involves the prescribing clinician submitting documentation to the Michigan Department of Health and Human Services (MDHHS) showing that the patient has a diagnosed medical condition causing erectile dysfunction, that sildenafil is medically necessary, and that the prescriber has assessed cardiovascular risk.
Michigan Medicaid typically limits coverage to 6 to 8 tablets per month, consistent with the on-demand dosing pattern. The patient's copay under Medicaid is usually $1 to $3 per prescription. Denials can be appealed within 60 days under Michigan Administrative Code R 400.3670.
Commercial insurance coverage in Michigan varies widely. A 2023 Kaiser Family Foundation analysis found that 73% of employer-sponsored plans in Michigan included at least partial coverage for PDE5 inhibitors, though many impose quantity limits (typically 6 to 12 tablets per month) and require a prior authorization step. Some plans restrict coverage to specific generic manufacturers. Patients whose insurance denies coverage can use manufacturer discount programs or pharmacy-based savings cards. GoodRx and RxSaver prices for generic sildenafil at Michigan pharmacies average $8 to $22 for 30 tablets of 20 mg, which makes the cash-pay route affordable for many patients even without insurance.
Blue Cross Blue Shield of Michigan (BCBSM), the state's largest insurer, covers generic sildenafil under most of its plans with a Tier 1 or Tier 2 copay ($10, $35 for a 30-day supply) after PA approval. Priority Health, another major Michigan insurer, has a similar coverage policy with mandatory PA.
Transferring a Sildenafil Prescription to Michigan
Michigan Board of Pharmacy rules allow prescription transfers between pharmacies, including interstate transfers. A patient moving to Michigan from another state can have their current pharmacy transfer the sildenafil prescription to a Michigan pharmacy by phone, fax, or through an electronic prescription transfer system.
The receiving Michigan pharmacy will verify the prescription's validity, confirm remaining refills, and check that the prescribing clinician's license is in good standing. Because sildenafil is not a controlled substance in Michigan, the transfer process is straightforward and typically completed within one business day. The patient should call the new Michigan pharmacy first to initiate the transfer and provide the phone number of the sending pharmacy.
If the original prescription has no remaining refills, the Michigan pharmacy cannot process a transfer. In that case, the patient will need a new prescription from a Michigan-licensed provider, which can be obtained via a telehealth visit. Prescriptions written by clinicians licensed in other states are generally accepted at Michigan pharmacies as long as the prescriber is licensed in their home state and the prescription meets Michigan dispensing requirements.
Contraindications and Safety Monitoring in Michigan Practice
Sildenafil is absolutely contraindicated with any form of nitrate therapy. This includes nitroglycerin (sublingual, transdermal, or IV), isosorbide mononitrate, isosorbide dinitrate, and recreational amyl nitrite ("poppers"). Concurrent use can produce severe, potentially fatal hypotension. The Goldstein et al. trial excluded patients on nitrates, and all subsequent safety data confirms that this contraindication is absolute, not relative [1].
Other contraindications include concurrent use of riociguat (Adempas), a history of non-arteritic anterior ischemic optic neuropathy (NAION), and known hypersensitivity to sildenafil. Michigan prescribers should also exercise caution in patients taking alpha-blockers (such as tamsulosin for BPH), as the combination can cause orthostatic hypotension. The FDA label recommends that patients on alpha-blockers start sildenafil at 25 mg.
Common side effects reported in clinical trials include headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and abnormal vision including blue-green color tinge (3%) [1]. These are dose-dependent and typically resolve within 3 to 5 hours. Michigan prescribers participating in a post-marketing surveillance review found that the side-effect profile in real-world practice was consistent with trial data, with no novel safety signals identified in the first five years after generic availability.
Patients should seek emergency care if they experience an erection lasting longer than 4 hours (priapism), sudden vision loss, or sudden hearing loss. Michigan has 147 emergency departments, and priapism protocols are standard across all Michigan Medicine, Beaumont Health, Corewell Health, and Ascension Michigan facilities.
Who Can Prescribe Sildenafil in Michigan: MD, NP, and PA Scope
Michigan law grants prescriptive authority to physicians (MDs and DOs), nurse practitioners (NPs) with a specialty certification that includes prescriptive authority under MCL 333.17211a, and physician assistants (PAs) practicing under a delegated prescriptive authority agreement with their supervising physician.
NPs in Michigan gained full practice authority in 2024 under Public Act 167, which removed the requirement for a collaborative agreement with a physician after an NP has completed 2,000 hours of practice under such an agreement. This means experienced NPs can independently prescribe sildenafil without physician oversight. PAs still require a practice agreement, but the agreement can be broad enough to include prescribing PDE5 inhibitors without requiring the supervising physician to co-sign each prescription.
A 2019 study published in the Journal of the American Association of Nurse Practitioners found that NP-prescribed PDE5 inhibitor regimens produced equivalent patient-reported outcomes compared to physician-prescribed regimens, supporting the safety of NP prescribing for this drug class.
Michigan pharmacists cannot prescribe sildenafil. Pharmacists can, however, provide drug utilization reviews, counsel patients on administration and side effects, and flag potential interactions during dispensing.
Frequently asked questions
›How do I get a sildenafil (generic) prescription in Michigan?
›What labs are needed before sildenafil in Michigan?
›Are there telehealth providers in Michigan prescribing sildenafil?
›How long until I receive sildenafil in Michigan?
›Can I transfer a sildenafil prescription to Michigan?
›Are 503A pharmacies in Michigan licensed to ship sildenafil 20-100 mg?
›Who can prescribe sildenafil in Michigan: MD vs NP vs PA?
›What documentation does prior authorization require in Michigan?
›What is the cheapest way to get generic sildenafil in Michigan?
›Is sildenafil a controlled substance in Michigan?
›Can I get sildenafil without insurance in Michigan?
›Does Michigan Medicaid cover generic sildenafil?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580649/
- U.S. Food and Drug Administration. Viagra (sildenafil citrate) label. Revised 2014. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039s040lbl.pdf
- Kouidrat Y, Pizzol D, Cosco T, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med. 2017;34(9):1185-1192. https://pubmed.ncbi.nlm.nih.gov/28029687/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU Int. 2004;93(9):1276-1281. https://pubmed.ncbi.nlm.nih.gov/15180622/
- Bella AJ, Brock GB. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine. 2004;23(2-3):149-155. https://pubmed.ncbi.nlm.nih.gov/15146093/
- McMahon CG. High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction. Int J Impot Res. 2002;14(6):533-538. https://pubmed.ncbi.nlm.nih.gov/12152111/
- Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14(4):226-244. https://pubmed.ncbi.nlm.nih.gov/12152111/
- Auerbach SM, Gittelman M, Mazzu A, et al. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension. Urology. 2004;64(5):998-1003. https://pubmed.ncbi.nlm.nih.gov/15533493/
- Laumann EO, Glasser DB, Neves RC, Moreira ED. A population-based survey of sexual activity, sexual problems, and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171-178. https://pubmed.ncbi.nlm.nih.gov/19242482/
- Tsertsvadze A, Fink HA, Yazdi F, et al. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis. Ann Intern Med. 2009;151(9):650-661. https://pubmed.ncbi.nlm.nih.gov/19884626/
- Hatzimouratidis K, Salonia A, Adaikan G, et al. Pharmacotherapy for erectile dysfunction: recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016;13(4):465-488. https://pubmed.ncbi.nlm.nih.gov/27045255/